These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31095959)

  • 21. Impact of formulation on the quality and stability of freeze-dried nanoparticles.
    Luo WC; O'Reilly Beringhs A; Kim R; Zhang W; Patel SM; Bogner RH; Lu X
    Eur J Pharm Biopharm; 2021 Dec; 169():256-267. PubMed ID: 34732383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting the Stability of Formulations Containing Lyophilized Human Serum Albumin and Sucrose/Trehalose Using Solid-State NMR Spectroscopy.
    Tower CW; Lay-Fortenbery A; Su Y; Munson EJ
    Mol Pharm; 2024 Jul; 21(7):3163-3172. PubMed ID: 38781678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryoprotectants for freeze drying of drug nano-suspensions: effect of freezing rate.
    Lee MK; Kim MY; Kim S; Lee J
    J Pharm Sci; 2009 Dec; 98(12):4808-17. PubMed ID: 19475555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mannitol/l-Arginine-Based Formulation Systems for Freeze Drying of Protein Pharmaceuticals: Effect of the l-Arginine Counter Ion and Formulation Composition on the Formulation Properties and the Physical State of Mannitol.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2016 Oct; 105(10):3123-3135. PubMed ID: 27506270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Arginine on the Aggregation of Protein in Freeze-Dried Formulations Containing Sugars and Polyol: II. BSA Reconstitution and Aggregation.
    Hackl E; Darkwah J; Smith G; Ermolina I
    AAPS PharmSciTech; 2018 Oct; 19(7):2934-2947. PubMed ID: 29980982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
    Anhorn MG; Mahler HC; Langer K
    Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Excipient Interactions on the State of the Freeze-Concentrate and Protein Stability.
    Jena S; Horn J; Suryanarayanan R; Friess W; Aksan A
    Pharm Res; 2017 Feb; 34(2):462-478. PubMed ID: 27981449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of crystallizing and non-crystallizing cosolutes on trehalose crystallization during freeze-drying.
    Sundaramurthi P; Suryanarayanan R
    Pharm Res; 2010 Nov; 27(11):2384-93. PubMed ID: 20824310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photolytic Labeling To Quantify Peptide-Water Interactions in Lyophilized Solids.
    Chen Y; Topp EM
    Mol Pharm; 2019 Mar; 16(3):1053-1064. PubMed ID: 30721080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moisture sorption behavior of selected bulking agents used in lyophilized products.
    Fakes MG; Dali MV; Haby TA; Morris KR; Varia SA; Serajuddin AT
    PDA J Pharm Sci Technol; 2000; 54(2):144-9. PubMed ID: 10822985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of protein/carbohydrate interactions in the dried state. 1. Calorimetric studies.
    Souillac PO; Costantino HR; Middaugh CR; Rytting JH
    J Pharm Sci; 2002 Jan; 91(1):206-16. PubMed ID: 11782910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Manufacturing and ambient stability of shelf freeze dried bacteriophage powder formulations.
    Zhang Y; Peng X; Zhang H; Watts AB; Ghosh D
    Int J Pharm; 2018 May; 542(1-2):1-7. PubMed ID: 29486286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excipients for the lyoprotection of MAPKAP kinase 2 inhibitory peptide nano-polyplexes.
    Mukalel AJ; Evans BC; Kilchrist KV; Dailing EA; Burdette B; Cheung-Flynn J; Brophy CM; Duvall CL
    J Control Release; 2018 Jul; 282():110-119. PubMed ID: 29709529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres.
    Cleland JL; Jones AJ
    Pharm Res; 1996 Oct; 13(10):1464-75. PubMed ID: 8899836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Influence of Mannitol Hemihydrate on the Secondary Drying Dynamics of a Protein Formulation: A Case Study.
    Srinivasan JM; Wegiel LA; Hardwick LM; Nail SL
    J Pharm Sci; 2017 Dec; 106(12):3583-3590. PubMed ID: 28867201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vacuum-Induced Surface Freezing for the Freeze-Drying of the Human Growth Hormone: How Does Nucleation Control Affect Protein Stability?
    Oddone I; Arsiccio A; Duru C; Malik K; Ferguson J; Pisano R; Matejtschuk P
    J Pharm Sci; 2020 Jan; 109(1):254-263. PubMed ID: 31002810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The formation and effect of mannitol hemihydrate on the stability of monoclonal antibody in the lyophilized state.
    Anko M; Bjelošević M; Planinšek O; Trstenjak U; Logar M; Ahlin Grabnar P; Brus B
    Int J Pharm; 2019 Jun; 564():106-116. PubMed ID: 30999044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes.
    Mohammed-Saeid W; Michel D; El-Aneed A; Verrall RE; Low NH; Badea I
    J Pharm Pharm Sci; 2012; 15(4):548-67. PubMed ID: 23106958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physicochemical characterization of the freezing behavior of mannitol-human serum albumin formulations.
    Hawe A; Friess W
    AAPS PharmSciTech; 2006; 7(4):94. PubMed ID: 17285745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of controlled ice nucleation and lyoprotectants on nanoparticle stability during Freeze-drying and upon storage.
    Luo WC; Zhang W; Kim R; Chong H; Patel SM; Bogner RH; Lu X
    Int J Pharm; 2023 Jun; 641():123084. PubMed ID: 37245738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.